Exposure to mitochondrial genotoxins and dopaminergic neurodegeneration in Caenorhabditis elegans

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  González Hunt, Claudia P ^a   Leung, Maxwell C K ^a   Bodhicharla, Rakesh K ^a   McKeever, Madeline G ^a   Arrant, Andrew E ^b   Margillo, Kathleen M ^a   Ryde, Ian T ^a   Cyr, Derek D ^a   Kosmaczewski, Sara G ^c   Hammarlund, Marc ^c   Meyer, Joel N ^a  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; CADMIUM CHLORIDE; MANEB; MANGANESE CHLORIDE; MITOCHONDRIAL DNA; OXIDOPAMINE; PARAQUAT; ROTENONE; ADRENERGIC RECEPTOR STIMULATING AGENT; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; MUTAGENIC AGENT;

ANALYSIS OF VARIANCE; ARTICLE; CAENORHABDITIS ELEGANS; CELL DAMAGE; CENTRIFUGATION; CONTROLLED STUDY; COPY NUMBER VARIATION; DENDRITE; DNA DAMAGE; DNA REPLICATION; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; ENVIRONMENTAL EXPOSURE; LASER; LETHALITY; MITOCHONDRION; MORPHOLOGY; NERVE DEGENERATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; REGENERATION; ULTRAVIOLET C RADIATION; ANIMAL; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; PATHOLOGY;

CAENORHABDITIS ELEGANS;

ADRENERGIC AGENTS; ANIMALS; CAENORHABDITIS ELEGANS; DNA DAMAGE; DNA, MITOCHONDRIAL; DOPAMINE; DOPAMINE AGENTS; DOPAMINERGIC NEURONS; MITOCHONDRIA; MUTAGENS; NERVE DEGENERATION; OXIDOPAMINE; PARAQUAT;

EID: 84915750909     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114459     Document Type: Article

References (127)

1. Schmidt CW (2010) Mito-Conundrum: Unraveling Environmental Effects on Mitochondria. Environ Health Perspect 118.
2. Shaughnessy DT, Worth L Jr, Lawler CP, McAllister KA, Longley MJ, et al. (2010) Meeting report: Identification of biomarkers for early detection of mitochondrial dysfunction. Mitochondrion 10: 579-581.
3. Bedard LL, Massey TE (2006) Aflatoxin B1-induced DNA damage and its repair. Cancer Lett 241: 174-183.
4. Meyer JN, Leung MCK, Rooney JP, Sendoel A, Hengartner MO, et al. (2013) Mitochondria as a Target of Environmental Toxicants. Toxicological Sciences 134: 1-17.
5. Wallace DC (2005) A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 39: 359-407.
6. Weissman L, De Souza-Pinto NC, Stevnsner T, Bohr VA (2007) DNA repair, mitochondria, and neurodegeneration. Neuroscience 145: 1318-1329.
7. Druzhyna NM, Wilson GL, LeDoux SP (2008) Mitochondrial DNA repair in aging and disease. Mech Ageing Dev 129: 383-390.
8. DiMauro S, Davidzon G (2005) Mitochondrial DNA and disease. Ann Med 37: 222-232.
9. Howell N, Elson JL, Chinnery PF, Turnbull DM (2005) mtDNA mutations and common neurodegenerative disorders. Trends Genet 21: 583-586.
10. Kohler JJ, Lewis W (2007) A brief overview of mechanisms of mitochondrial toxicity from NRTIs. Environ Mol Mutagen 48: 166-172.
11. Wunderlich V, Schutt M, Bottger M, Graffi A (1970) Preferential alkylation of mitochondrial deoxyribonucleic acid by N-methyl-N-nitrosourea. Biochem J 118: 99-109.
12. Wunderlich V, Tetzlaff I, Graffi A (1972) Studies on nitrosodimethylamine: preferential methylation of mitochondrial DNA in rats and hamsters. Chem Biol Interact 4: 81-89.
13. Backer JM, Weinstein IB (1982) Interaction of benzo(a)pyrene and its dihydrodiol-epoxide derivative with nuclear and mitochondrial DNA in C3H10T 1/2 cell cultures. Cancer Res 42: 2764-2769.
14. Cohen BH (2010) Pharmacologic effects on mitochondrial function. Developmental Disabilities Research Reviews 16: 189-199.
15. Larsen NB, Rasmussen M, Rasmussen LJ (2005) Nuclear and mitochondrial DNA repair: similar pathways? Mitochondrion 5: 89-108.
16. Meyer JN (2010) QPCR: a tool for analysis of mitochondrial and nuclear DNA damage in ecotoxicology. Ecotoxicology 19: 804-811.
17. Van Houten B, Woshner V, Santos JH (2006) Role of mitochondrial DNA in toxic responses to oxidative stress. DNA Repair (Amst) 5: 145-152.
18. Gomez C, Bandez MJ, Navarro A (2007) Pesticides and impairment of mitochondrial function in relation with the parkinsonian syndrome. Front Biosci 12: 1079-1093.
19. Ishiguro H, Yasuda K, Ishii N, Ihara K, Ohkubo T, et al. (2001) Enhancement of oxidative damage to cultured cells and Caenorhabditis elegans by mitochondrial electron transport inhibitors. IUBMB Life 51: 263-268.
20. Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, et al. (2003) Mitochondrial Complex I Inhibitor Rotenone Induces Apoptosis through Enhancing Mitochondrial Reactive Oxygen Species Production. Journal of Biological Chemistry 278: 8516-8525.
21. Yakes FM, Van Houten B (1997) Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci U S A 94: 514-519.
22. Allen JA, Coombs MM (1980) Covalent binding of polycyclic aromatic compounds to mitochondrial and nuclear DNA. Nature 287: 244-245.
23. Ayala-Torres S, Chen Y, Svoboda T, Rosenblatt J, Van Houten B (2000) Analysis of gene-specific DNA damage and repair using quantitative polymerase chain reaction. Methods 22: 135-147.
24. Brar SS, Meyer JN, Bortner C, Van Houten B, Martin WJ II (2012) Mitochondrial DNA-depleted A549 cells are resistant to bleomycin. American Journal of Physiology - Lung Cellular and Molecular Physiology.
25. Boamah EK, Brekman A, Tomasz M, Myeku N, Figueiredo-Pereira M, et al. (2010) DNA adducts of decarbamoyl mitomycin C efficiently kill cells without wild-type p53 resulting from proteasome-mediated degradation of checkpoint protein 1. Chem Res Toxicol 23: 1151-1162.
26. Hunter SE, Gustafson MA, Margillo KM, Lee SA, Ryde IT, et al. (2012) In vivo repair of alkylating and oxidative DNA damage in the mitochondrial and nuclear genomes of wild-type and glycosylase-deficient Caenorhabditis elegans. DNA Repair (Amst) 11: 857-863.
27. DiMauro S, Schon EA (2008) Mitochondrial disorders in the nervous system. Annu Rev Neurosci 31: 91-123.
28. Pinto M, Pickrell AM, Moraes CT (2012) Regional susceptibilities to mitochondrial dysfunctions in the CNS. Biol Chem 393: 275-281.
29. Wang X, Michaelis EK (2010) Selective neuronal vulnerability to oxidative stress in the brain. Frontiers in Aging Neuroscience 2.
30. Fukui H, Moraes CT (2008) The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis? Trends Neurosci 31: 251-256.
31. Pinto M, Moraes CT (2013) Mitochondrial genome changes and neurodegenerative diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.
32. Kraytsberg Y, Kudryavtseva E, McKee AC, Geula C, Kowall NW, et al. (2006) Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet 38: 518-520.
33. Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, et al. (2006) High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 38: 515-517.
34. Wang J, Xiong S, Xie C, Markesbery WR, Lovell MA (2005) Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. Journal of Neurochemistry 93: 953-962.
35. Alam ZI, Jenner A, Daniel SE, Lees AJ, Cairns N, et al. (1997) Oxidative DNA Damage in the Parkinsonian Brain: An Apparent Selective Increase in 8-Hydroxyguanine Levels in Substantia Nigra. Journal of Neurochemistry 69: 1196-1203.
36. Polidori MC, Mecocci P, Browne SE, Senin U, Beal MF (1999) Oxidative damage to mitochondrial DNA in Huntington's disease parietal cortex. Neuroscience Letters 272: 53-56.
37. Mecocci P, MacGarvey U, Beal MF (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 36: 747-751.
38. Pickrell AM, Pinto M, Hida A, Moraes CT (2011) Striatal Dysfunctions Associated with Mitochondrial DNA Damage in Dopaminergic Neurons in a Mouse Model of Parkinson's Disease. The Journal of Neuroscience 31: 17649-17658.
39. Sanders LH, McCoy J, Hu X, Mastroberardino PG, Dickinson BC, et al. (2014) Mitochondrial DNA damage: Molecular marker of vulnerable nigral neurons in Parkinson's disease. Neurobiology of Disease 70: 214-223.
40. Luoma P, Melberg A, Rinne JO, Kaukonen JA, Nupponen NN, et al. (2004) Parkinsonism, premature menopause, and mitochondrial DNA polymerase c mutations: clinical and molecular genetic study. The Lancet 364: 875-882.
41. Graziewicz MA, Bienstock RJ, Copeland WC (2007) The DNA polymerase c Y955C disease variant associated with PEO and parkinsonism mediates the incorporation and translesion synthesis opposite 7,8-dihydro-8-oxo-2′-deoxyguanosine. Human Molecular Genetics 16: 2729-2739.
42. Bronstein J, Carvey P, Chen H, Cory-Slechta D, DiMonte D, et al. (2009) Meeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007. Environ Health Perspect 117: 117-121.
43. Dinis-Oliveira RJ, Remiao F, Carmo H, Duarte JA, Navarro AS, et al. (2006) Paraquat exposure as an etiological factor of Parkinson's disease. Neurotoxicology 27: 1110-1122.
44. Guilarte TR (2010) Manganese and Parkinson's disease: a critical review and new findings. Environ Health Perspect 118: 1071-1080.
45. Bronstein J, Carvey P, Chen H, Cory-Slechta D, DiMonte D, et al. (2008) Meeting Report: Consensus Statement - Parkinson's Disease and the Environment: Collaborative on Health and the Environment and Parkinson's Action Network (CHE PAN) Conference 26-28 June 2007. Environ Health Perspect 117.
46. Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, et al. (2011) Rotenone, paraquat, and Parkinson's disease. Environ Health Perspect 119: 866-872.
47. Cannon JR, Greenamyre JT (2011) The Role of Environmental Exposures in Neurodegeneration and Neurodegenerative Diseases. Toxicological Sciences 124: 225-250.
48. van der Mark M, Brouwer M, Kromhout H, Nijssen P, Huss A, et al. (2012) Is pesticide use related to Parkinson disease? Some clues to heterogeneity in study results. Environ Health Perspect 120: 340-347.
49. Benedetto A, Au C, Aschner M (2009) Manganese-induced dopaminergic neurodegeneration: insights into mechanisms and genetics shared with Parkinson's disease. Chem Rev 109: 4862-4884.
50. Franco R, Li S, Rodriguez-Rocha H, Burns M, Panayiotidis MI (2010) Molecular mechanisms of pesticide-induced neurotoxicity: Relevance to Parkinson's disease. Chem Biol Interact 188: 289-300.
51. Barlow BK, Cory-Slechta DA, Richfield EK, Thiruchelvam M (2007) The gestational environment and Parkinson's disease: evidence for neurodevelopmental origins of a neurodegenerative disorder. Reprod Toxicol 23: 457-470.
52. Borenstein AR, Copenhaver CI, Mortimer JA (2006) Early-life risk factors for Alzheimer disease. Alzheimer Dis Assoc Disord 20: 63-72.
53. Miller DB, O'Callaghan JP (2008) Do early-life insults contribute to the late-life development of Parkinson and Alzheimer diseases? Metabolism 57 Suppl 2: S44-49.
54. Shoubridge EA, Wai T (2007) Mitochondrial DNA and the Mammalian Oocyte. In:, Justin CSJ, , editor., Current Topics in Developmental Biology: Academic Press. pp. 87-111.
55. Nass R, Hall DH, Miller DM 3rd, Blakely RD (2002) Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans. Proc Natl Acad Sci U S A 99: 3264-3269.
56. Williams PL, Dusenbery DB (1988) Using the nematode Caenorhabditis elegans to predict mammalian acute lethality to metallic salts. Toxicol Ind Health 4: 469-478.
57. Boyd WA, Smith MV, Kissling GE, Rice JR, Snyder DW, et al. (2009) Application of a Mathematical Model to Describe the Effects of Chlorpyrifos on Caenorhabditis elegans Development. PLoS ONE 4: e7024.
58. Leung MC, Goldstone JV, Boyd WA, Freedman JH, Meyer JN (2010) Caenorhabditis elegans generates biologically relevant levels of genotoxic metabolites from aflatoxin B1 but not benzo[a]pyrene in vivo. Toxicol Sci 118: 444-453.
59. Hunter SE, Jung D, Di Giulio RT, Meyer JN (2010) The QPCR assay for analysis of mitochondrial DNA damage, repair, and relative copy number. Methods 51: 444-451.
60. Furda AM, Bess AS, Meyer JN, Van Houten B (2012) Analysis of DNA damage and repair in nuclear and mitochondrial DNA of animal cells using quantitative PCR. Methods Mol Biol 920: 111-132.
61. Meyer JN, Boyd WA, Azzam GA, Haugen AC, Freedman JH, et al. (2007) Decline of nucleotide excision repair capacity in aging Caenorhabditis elegans. Genome Biol 8: R70.
62. Sulston JE (1988) Cell Lineage. In The Nematode Caenorhabditis elegans: Cold Spring Harbor Laboratory Press.
63. Bess AS, Crocker TL, Ryde IT, Meyer JN (2012) Mitochondrial dynamics and autophagy aid in removal of persistent mitochondrial DNA damage in Caenorhabditis elegans. Nucleic Acids Res.
64. Leung M, Rooney J, Ryde I, Bernal A, Bess A, et al. (2013) Effects of early life exposure to ultraviolet C radiation on mitochondrial DNA content, transcription, ATP production, and oxygen consumption in developing Caenorhabditis elegans. BMC Pharmacology and Toxicology 14: 9.
65. Tsang WY, Sayles LC, Grad LI, Pilgrim DB, Lemire BD (2001) Mitochondrial respiratory chain deficiency in Caenorhabditis elegans results in developmental arrest and increased life span. J Biol Chem 276: 32240-32246.
66. Byrne AB, Edwards TJ, Hammarlund M (2011) In vivo Laser Axotomy in C. elegans. e2707.
67. Larosche I, Letteron P, Berson A, Fromenty B, Huang TT, et al. (2010) Hepatic mitochondrial DNA depletion after an alcohol binge in mice: probable role of peroxynitrite and modulation by manganese superoxide dismutase. J Pharmacol Exp Ther 332: 886-897.
68. Korr H, Botzem B, Schmitz C, Enzmann H (2001) N-Nitrosomorpholine induced alterations of unscheduled DNA synthesis, mitochondrial DNA synthesis and cell proliferation in different cell types of liver, kidney, and urogenital organs in the rat. Chem Biol Interact 134: 217-233.
69. Santos JH, Meyer JN, Mandavilli BS, Van Houten B (2006) Quantitative PCR-based measurement of nuclear and mitochondrial DNA damage and repair in mammalian cells. Methods Mol Biol 314: 183-199.
70. Benedetto A, Au C, Avila DS, Milatovic D, Aschner M (2010) Extracellular Dopamine Potentiates Mn- Induced Oxidative Stress, Lifespan Reduction, and Dopaminergic Neurodegeneration in a BLI-3- Dependent Manner in Caenorhabditis elegans. PLoS Genet 6: e1001084.
71. Negga R, Rudd DA, Davis NS, Justice AN, Hatfield HE, et al. (2011) Exposure to Mn/Zn ethylene-bisdithiocarbamate and glyphosate pesticides leads to neurodegeneration in Caenorhabditis elegans. Neurotoxicology 32: 331-341.
72. Ruan Q, Harrington AJ, Caldwell KA, Caldwell GA, Standaert DG (2010) VPS41, a protein involved in lysosomal trafficking, is protective in Caenorhabditis elegans and mammalian cellular models of Parkinson's disease. Neurobiology of Disease 37: 330-338.
73. Saha S, Guillily MD, Ferree A, Lanceta J, Chan D, et al. (2009) LRRK2 Modulates Vulnerability to Mitochondrial Dysfunction in Caenorhabditis elegans. The Journal of Neuroscience 29: 9210-9218.
74. Zhou S, Wang Z, Klaunig JE (2013) Caenorhabditis elegans neuron degeneration and mitochondrial suppression caused by selected environmental chemicals. Int J Biochem Mol Biol 4: 191-200.
75. Samokhvalov V, Scott BA, Crowder CM (2008) Autophagy protects against hypoxic injury in C. elegans. Autophagy 4: 1034-1041.
76. Yu BP, Chung HY (2001) Stress Resistance by Caloric Restriction for Longevity. Annals of the New York Academy of Sciences 928: 39-47.
77. Sohal RS, Weindruch R (1996) Oxidative stress, caloric restriction, and aging. Science 273: 59-63.
78. Martin B, Mattson MP, Maudsley S (2006) Caloric restriction and intermittent fasting: Two potential diets for successful brain aging. Ageing Research Reviews 5: 332-353.
79. Nass R, Hamza I (2007) The Nematode C. elegans as an Animal Model to Explore Toxicology In Vivo: Solid and Axenic Growth Culture Conditions and Compound Exposure Parameters. Current Protocols in Toxicology: John Wiley & Sons, Inc.
80. Bejjani RE, Hammarlund M (2012) Neural Regeneration in Caenorhabditis elegans. Annual Review of Genetics 46: 499-513.
81. Hammarlund M, Nix P, Hauth L, Jorgensen EM, Bastiani M (2009) Axon regeneration requires a conserved MAP kinase pathway. Science 323: 802-806.
82. Yan D, Wu Z, Chisholm AD, Jin Y (2009) The DLK-1 kinase promotes mRNA stability and local translation in C. elegans synapses and axon regeneration. Cell 138: 1005-1018.
83. Gaines G, Attardi G (1984) Intercalating drugs and low temperatures inhibit synthesis and processing of ribosomal RNA in isolated human mitochondria. J Mol Biol 172: 451-466.
84. Jones GM, Vale JA (2000) Mechanisms of toxicity, clinical features, and management of diquat poisoning: a review. J Toxicol Clin Toxicol 38: 123-128.
85. Yumino K, Kawakami I, Tamura M, Hayashi T, Nakamura M (2002) Paraquat- and diquat-induced oxygen radical generation and lipid peroxidation in rat brain microsomes. J Biochem 131: 565-570.
86. Salazar JJ, Van Houten B (1997) Preferential mitochondrial DNA injury caused by glucose oxidase as a steady generator of hydrogen peroxide in human fibroblasts. Mutat Res 385: 139-149.
87. Santos JH, Hunakova L, Chen Y, Bortner C, Van Houten B (2003) Cell sorting experiments link persistent mitochondrial DNA damage with loss of mitochondrial membrane potential and apoptotic cell death. J Biol Chem 278: 1728-1734.
88. Cover C, Mansouri A, Knight TR, Bajt ML, Lemasters JJ, et al. (2005) Peroxynitrite-induced mitochondrial and endonuclease-mediated nuclear DNA damage in acetaminophen hepatotoxicity. J Pharmacol Exp Ther 315: 879-887.
89. Hollins DL, Suliman HB, Piantadosi CA, Carraway MS (2006) Glutathione regulates susceptibility to oxidant-induced mitochondrial DNA damage in human lymphocytes. Free Radic Biol Med 40: 1220-1226.
90. Cocheme HM, Murphy MP (2008) Complex I is the major site of mitochondrial superoxide production by paraquat. J Biol Chem 283: 1786-1798.
91. Drechsel DA, Patel M (2009) Chapter 21 Paraquat-induced production of reactive oxygen species in brain mitochondria. Methods Enzymol 456: 381-393.
92. Suzuki J, Inoue Y, Suzuki S (1995) Changes in the urinary excretion level of 8-hydroxyguanine by exposure to reactive oxygen-generating substances. Free Radic Biol Med 18: 431-436.
93. Tokunaga I, Kubo S, Mikasa H, Suzuki Y, Morita K (1997) Determination of 8-hydroxydeoxyguanosine formation in rat organs: assessment of paraquat-evoked oxidative DNA damage. Biochem Mol Biol Int 43: 73-77.
94. Niranjan BG, Bhat NK, Avadhani NG (1982) Preferential attack of mitochondrial DNA by aflatoxin B1 during hepatocarcinogenesis. Science 215: 73-75.
95. Niranjan BG, Schaefer H, Ritter C, Avadhani NG (1986) Protection of mitochondrial genetic system against aflatoxin B1 binding in animals resistant to aflatoxicosis. Cancer Res 46: 3637-3641.
96. Sajan MP, Satav JG, Bhattacharya RK (1996) Alteration of energy-linked functions in rat hepatic mitochondria following aflatoxin B1 administration. J Biochem Toxicol 11: 235-241.
97. Sajan MP, Satav JG, Bhattacharya RK (1997) Effect of aflatoxin B in vitro on rat liver mitochondrial respiratory functions. Indian J Exp Biol 35: 1187-1190.
98. Ergun E, Ergun L, Essiz D (2006) Light and electron microscopic studies on liver histology in chicks fed aflatoxin. Dtsch Tierarztl Wochenschr 113: 363-368.
99. Groopman JD, Kensler TW (2005) Role of metabolism and viruses in aflatoxin-induced liver cancer. Toxicol Appl Pharmacol 206: 131-137.
100. Loft S, Deng XS, Tuo J, Wellejus A, Sorensen M, et al. (1998) Experimental study of oxidative DNA damage. Free Radic Res 29: 525-539.
101. Mandavilli BS, Ali SF, Van Houten B (2000) DNA damage in brain mitochondria caused by aging and MPTP treatment. Brain Research 885: 45-52.
102. Kazak L, Reyes A, Holt IJ (2012) Minimizing the damage: repair pathways keep mitochondrial DNA intact. Nat Rev Mol Cell Biol 13: 659-671.
103. Brooks PJ (2007) The case for 8,5′-cyclopurine-2′-deoxynucleosides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum. Neuroscience 145: 1407-1417.
104. Joseph P (2009) Mechanisms of cadmium carcinogenesis. Toxicol Appl Pharmacol 238: 272-279.
105. Cannino G, Ferruggia E, Luparello C, Rinaldi AM (2009) Cadmium and mitochondria. Mitochondrion 9: 377-384.
106. Kurochkin IO, Etzkorn M, Buchwalter D, Leamy L, Sokolova IM (2011) Top-down control analysis of the cadmium effects on molluscan mitochondria and the mechanisms of cadmium-induced mitochondrial dysfunction. Am J Physiol Regul Integr Comp Physiol 300: R21-31.
107. Bernstein A, Garrison S, Zambetti G, O'Malley K (2011) 6-OHDA generated ROS induces DNA damage and p53- and PUMA-dependent cell death. Molecular Neurodegeneration 6: 2.
108. Blum D, Torch S, Lambeng N, Nissou M-F, Benabid A-L, et al. (2001) Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Progress in Neurobiology 65: 135-172.
109. Kobayashi H, Oikawa S, Umemura S, Hirosawa I, Kawanishi S (2008) Mechanism of metal-mediated DNA damage and apoptosis induced by 6-hydroxydopamine in neuroblastoma SH-SY5Y cells. Free Radical Research 42: 651-660.
110. Rooney JP, Luz AL, Gonzalez-Hunt CP, Bodhicharla R, Ryde IT, et al. (2014) Effects of 5′-Fluoro-2-deoxyuridine on Mitochondrial Biology in Caenorhabditis elegans. Exp Gerontol.
111. Mendenhall AR, LeBlanc MG, Mohan DP, Padilla PA (2009) Reduction in ovulation or male sex phenotype increases long-term anoxia survival in a daf-16-independent manner in Caenorhabditis elegans. Physiol Genomics 36: 167-178.
112. Schapira AHV (2008) Mitochondria in the aetiology and pathogenesis of Parkinson's disease. The Lancet Neurology 7: 97-109.
113. Sulzer D (2007) Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease. Trends Neurosci 30: 244-250.
114. Cao L, Shitara H, Horii T, Nagao Y, Imai H, et al. (2007) The mitochondrial bottleneck occurs without reduction of mtDNA content in female mouse germ cells. Nat Genet 39: 386-390.
115. Bratic I, Hench J, Henriksson J, Antebi A, Burglin TR, et al. (2009) Mitochondrial DNA level, but not active replicase, is essential for Caenorhabditis elegans development. Nucleic Acids Res 37: 1817-1828.
116. Tsang WY, Lemire BD (2002) Mitochondrial genome content is regulated during nematode development. Biochem Biophys Res Commun 291: 8-16.
117. Graziewicz MA, Sayer JM, Jerina DM, Copeland WC (2004) Nucleotide incorporation by human DNA polymerase gamma opposite benzo[a]pyrene and benzo[c]phenanthrene diol epoxide adducts of deoxyguanosine and deoxyadenosine. Nucleic Acids Res 32: 397-405.
118. Cline SD, Lodeiro MF, Marnett LJ, Cameron CE, Arnold JJ (2010) Arrest of human mitochondrial RNA polymerase transcription by the biological aldehyde adduct of DNA, M1dG. Nucleic Acids Res 38: 7546-7557.
119. Gredilla R, Barja G (2005) Minireview: The Role of Oxidative Stress in Relation to Caloric Restriction and Longevity. Endocrinology 146: 3713-3717.
120. Maalouf M, Rho JM, Mattson MP (2009) The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Research Reviews 59: 293-315.
121. Maswood N, Young J, Tilmont E, Zhang Z, Gash DM, et al. (2004) Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease. Proceedings of the National Academy of Sciences 101: 18171-18176.
122. Sachs C, Jonsson G (1975) Mechanisms of action of 6-hydroxydopamine. Biochem Pharmacol 24: 1-8.
123. Landrigan PJ, Sonawane B, Butler RN, Trasande L, Callan R, et al. (2005) Early environmental origins of neurodegenerative disease in later life. Environ Health Perspect 113: 1230-1233.
124. Liou HH, Tsai MC, Chen CJ, Jeng JS, Chang YC, et al. (1997) Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology 48: 1583-1588.
125. Priyadarshi A, Khuder SA, Schaub EA, Priyadarshi SS (2001) Environmental risk factors and Parkinson's disease: a metaanalysis. Environ Res 86: 122-127.
126. Melrose H, Lincoln S, Tyndall G, Farrer M (2006) Parkinson's disease: a rethink of rodent models. Experimental Brain Research 173: 196-204.
127. Cicchetti F, Drouin-Ouellet J, Gross RE (2009) Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models? Trends in Pharmacological Sciences 30: 475-483.